Invention Grant
- Patent Title: Bodily substance detection by evaluating photoluminescent response to excitation radiation
-
Application No.: US15177888Application Date: 2016-06-09
-
Publication No.: US10709505B2Publication Date: 2020-07-14
- Inventor: Ralf Brinkmann , Birgit Lange
- Applicant: Boston Scientific Scimed, Inc.
- Applicant Address: US MA Maple Grove
- Assignee: Boston Scientific Corporation
- Current Assignee: Boston Scientific Corporation
- Current Assignee Address: US MA Maple Grove
- Agency: Bookoff McAndrews, PLLC
- Main IPC: A61B18/26
- IPC: A61B18/26 ; A61B18/24 ; A61B5/00 ; A61B18/20 ; A61B5/06 ; A61B18/00 ; A61B5/20 ; A61B17/00

Abstract:
A medical device may include an ablation device configured to deliver ablation energy to a treatment site. The medical device may further include a probe device configured to deliver excitation radiation to the treatment site. Further the medical device may include a radiation-receiving device configured to receive photoluminescence radiation emitted from the treatment site in response to the treatment site being illuminated by the excitation radiation and to generate a detection signal in response to the received photoluminescence radiation. Additionally, the excitation radiation may be different from the ablation energy.
Public/Granted literature
- US20160361120A1 BODILY SUBSTANCE DETECTION BY EVALUATING PHOTOLUMINESCENT RESPONSE TO EXCITATION RADIATION Public/Granted day:2016-12-15
Information query